David Chang, WuXi AppTec

A 'love sto­ry': WuXi AppTec wraps UK-based CRO in­to its cell and gene ther­a­py unit

When WuXi AppTec, one of Chi­na’s largest con­tract re­search or­ga­ni­za­tions, start­ed work­ing with UK-based Ox­gene about a year ago, it was “love at first sight …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.